George Washington University / Berman Institute of Bioethics / American College of Medical Genetics / Laboratory Developed Tests / College of American Pathologists / Columbia College / Michigan State University / Johns Hopkins University / /
IndustryTerm
potential and actual clinical applications / state law / appropriate software / urban development law / manufacturers distributing devices / public finance / imaging / moderaterisk devices / energy / pharmaceuticals / device manufacturers / potential clinical applications / genetic testing services / disease management / electronic devices / test systems / biological products / in-house protocol / laboratory information systems / predicate device / study protocol / manufacturing practices / improved sequencing technologies / devices stand-alone software / diagnostic product / reaction products / federal election law / healthcare / health-related testing services / diagnostic products / standalone software / interpretive services / computer algorithms / healthcare practitioners / test services / treatment of any disease / medical device data systems / medical devices certain test systems / tests as device / software programs / healthcare decisions / base-specific chemical cleavage / gene-expression-profiling test systems / /
MedicalCondition
neurological disorders / serious injury / injury / breast cancer / cancer / genetic disease / Dissect Neurological Disease / inherited disorders / disease / /
Organization
House Energy and Commerce Committee / Research Faculty / College of American Pathologists / Medicare / George Washington University in Washington / the American College / FDA / Statutory Authority / Michigan State University / Harvard Law School / Food and Drug Administration / Columbia College / New York / Berman Institute of Bioethics / PHG Foundation / Johns Hopkins University / National Academy of Sciences / Senate HELP Committee / Congress / federal government / National Center for Biotechnology Information / Department of Health and Human Services / U.S. Centers for Disease Control and Prevention / /
Person
J. C. Venter / Katherine Strong Carner / Allan Maxam / Fred Sanger / Gail H. Javitt / Walter Gilbert / Elizabeth Mansfield / /
PoliticalEvent
federal election / /
Position
Generation Cardiologist / Secretary / Official / counsel / Director for Personalized Medicine within OIR / /
ProvinceOrState
New York / Washington / Michigan / Texas / Maryland / Massachusetts / /
PublishedMedium
Proceedings of the National Academy of Sciences / Nature Reviews Genetics / Nature Biotechnology / /
Technology
Neuroscience / diagnostic tests / genotyping / human genome / improved sequencing technologies / DNA Chip / gene expression / submission.68 The study protocol / gel electrophoresis / Genomics / bioinformatics / DNA sequencing technology / electrophoresis / Biotechnology / in-house protocol / computer algorithms / 2nd/3rd/4th-generation sequencing technologies / DNA synthesis / DNA Sequencing / open-sourced algorithms / /
Regulation of Next Generation Sequencing Gail H. Javitt and Katherine Strong Carner Introduction Since the first draft of the human genome was published in 2001,1 DNA sequencing technology has